AMGN Stock: Amgen Inc. Stock Price, Analysis & Insights
Get live AMGN stock price $339.30, comprehensive Amgen Inc. stock analysis, charts, news, and expert forecast. Real-time AMGN stock data and investment insights.
Loading chart data...
Amgen Inc. (AMGN) Overview
Amgen Inc. (AMGN) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - General industry . As of the latest trading session, AMGN trades at $339.30 with a market capitalization of 183.12B . Over the past 52 weeks, AMGN has traded between $267.83 and $391.29 , with the current price positioned at approximately 58% of this range . The stock currently...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - General)
- Market cap: 183.12B
- Current price: $339.30
- 52-week range: $267.83 - $391.29
- P/E ratio: 23.61
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel t...
Company Information
- CEO
- Robert A. Bradway
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 28000
Contact Information
- Website
- https://www.amgen.com
- Address
- One Amgen Center Drive
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Market leader with 183.1 billion market capitalization
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 23.6)
✓ Lower volatility stock (Beta: 0.43) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Amgen Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Amgen Inc.
- ⚠Investors should consider how Amgen Inc. fits within their overall portfolio allocation
Market Cap
183.12B
P/E Ratio (TTM)
23.61
Beta
0.43
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Healthcare Stocks
Compare AMGN with:
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.